Rearrangement of the immunoglobulin (lg) and T cell receptor (TCR) gene loci allows for the generation of B and T lymphocytes with antigen-specific receptors. Complete rearrangement and expression of the TCtL-[3 chain enables immature thymocytes to differentiate from the CD4-CD8-to the CD4+CD8 + stage. Mice in which rearrangement is impaired, such as severe combined immunodeficient (SCID) mice or recombinase activating gene-deficient (RAG -/-) mice, lack mature B and T lymphocytes. Thymocytes from these mice are arrested at the CD4-CD8-stage of T cell development. We previously observed that thymocytes from RAG-2 -/-mice exposed to "y radiation differentiate from CD4-CD8-into CD4+CD8 + without TCR-[3 chain rearrangement. We now report that irradiated RAG-2 -/-thymocytes undergo direct somatic mutations at the p53 gene locus, and that p53 inactivation is associated with maturation of RAG-2 -/-thymocytes to the CD4+CD8 + stage. Generation of RAG-2 -/-and p53 -/-double-deficient mice revealed that, in the absence of TCR-[3 chain rearrangement, loss of p53 function is sufficient for CD4-CD8-thymocytes to differentiate into the CD4*CD8 + stage ofT cell development. Our data provide evidence for a novel p53-mediated checkpoint in early thymocyte development that regulates the transition of CD4-CD8-into CD4+CD8 + thymocytes.
A
daptive immunity requires the establishment of a large repertoire of lymphocytes, each beating a unique anugen-specific receptor. Successful rearrangement ofTCtL gene loci is necessary for proper thymocyte development and for the generation of a mature T cell repertoire. Mice with recombination deficiencies, such as SCID and RAG -/-, display a differenuation arrest early in T cell development and lack receptor-beating T cells in the periphery (l-3). In these mice, thymocyte development does not proceed further than the early immature CD4-CD8-(double-negative, DN) stage. Recent evidence supports the notion that signals derived from a pre-To~ chain and a fully rearranged TCIL-[3 chain at the DN stage drive thymocyte differentiation to the next point in development, the CD4+CD8 + (double-positive, DP) stage (4) (5) (6) . This TCP,.-[3 chainmediated differentiation event has been termed "[3 selection" (6) (7) (8) . Once thymocytes reach the DP stage, TCR-ot chain rearrangement occurs, allowing for the TCR-MHC interactions that result an the negative or positive selecuon of developmg thymocytes (9, 10) .
We recently reported that DN thymocytes from RAG-2 -/-mice differentiate into DP thymocytes after exposure to ~ radiauon, and that this induced differentiation occurs in the absence of TCR- [3 rearrangement (1l) . Because of their inability to recombine their TCR gene loci, DN thymocytes from RAG-2 -/-mice have a limited developmental potential and a shortened fife span (4, 7) . This limited life span may reflect a dominant programmed cell death (apoptosis) pathway that is normally suppressed by TCP~-[3 signals. We hypothesized that thymocytes from irradiated RAG-2 -/-mice acquire a novel phenotype that permats them to proceed with thymocyte development by superseding the required TCIL-[3 differentiation signals. DP thymocytes induced by radiation may have failed to respond to the appropriate death signals that DN cells normally receive in the absence of TCR-[3 selection. To address this possibxlity, we investigated genes involved m the apoptosis pathway that may be responsible for inducing death of DN thymocytes that fail to rearrange TCR-[3 gene loci.
One of the key regulatory genes involved in the induction of apoptosis is p53 (12) . Cells with mutant forms of p53 are resistant to several inducers of apoptosis, such as DNA damage (12, 13) . This is most evident in the preponderance of human tumors known to have a mutated form of the p53 gene, which is thought to lead to a deregulated neoplastic phenotype (12, 14) . Furthermore, the p53 gene contains several regions, known as "hot spots," that are highly susceptible to direct somatic mutations from exposure to radiation or DNA-damaging agents (15) . In this report, we show that irradiated RAG-2 -/-thymocytes acquire radiation-induced somatic mutations of the p53 gene, which can enable DN thymocytes to advance to the DP stage m the absence of TCtL-I3 survival/differentiation signals. We directly demonstrate the involvement of p53 during DNto-DP thymocytes differentiation by showing that DN thymocytes differentiate to the DP stage ofT cell development in tLAG-2-/-/p53 -/-double-deficient mice. Thus, in the absence of TCR-I3 chain rearrangement, loss of p53 function is sufficient for the transition of CD4-CD8-into CD4+CD8 + thymocytes.
Materials and Methods
Mice. RAG-2 -/-mice were obtained from Dr. Flow Cytometry. Antibodies for flow cytometry were purchased from PharMingen (San Diego, CA). Staining ofceUs was performed as previously described (16) .
RNA and PCR Analysis. Total RNA from thymocytes was prepared wath tLNAzol (Tel-Test Inc., Friendswood, TX) as indicated by the manufacturer. Reverse transcriptase (P,T)-PCR. analysis and cloning of p53 were performed using standard techmques.
I/riefly, P,.T reactions were performed with isolated RNA from thymocytes of control or 2-wk postirradiation RAG-2 -/-mice using random hexamer primers. The first-strand cDNA products were amphfied by PCR using pfu DNA polymerase with p53 gene-speclfic primers (5' CCT GTC ATC TTT TGT CCC TTC TCA 3', for the upper primer at position 424, and 5' ATA AGA CAG CAA GGA GAG GGG GAG 3', for the lower primer at position 1361). The PCR_ product was analyzed by gel electrophoresis or cloned using the T/A cloning system (lnvitrogen, San Diego, CA). Plasmids containing the p53 gene were sequenced with several gene-specific primers using the Sequenase 2.0 system (Amersham Corp., Arlington Heights, IL).
Immunoprecipitation and Western Blot Analysis. Thymocyte nuclear extracts were prepared as previously described (17) . Nuclear extracts were lmmunoprecipltated with either Pab-246 or Pab-240 mAb (Santa Cruz Biotechnology Inc., Santa Cruz, CA) for the wild-type or mutant forms of p53, respecuvely. SDS-PAGE was performed on immunoprecipltated material and electroblotted onto nitrocellulose membranes. Immunoblots were hybridized using Pab-240 mAb, which recognizes both wild-type and mutant forms of denatured/membrane-bound p53. Polyclonal antl-mouse-K/h-HRP-labeled lg (Southern Biotechnology Associates, Barmingham, AL) was used to detect the hybridizing anubody. The ECL system (Amersham Corp.) was used to detect the secondary antibody.
Results and Discussion
Thymocytes from recombination-deficient (RAG-2-'-) mice are blocked at the DN stage of T cell development (Fig. 1) . Thymocytes from RAG-2 -/-mice exposed to sublethal doses of ~/radiation show the appearance of DP cells 2 wk after treatment (Fig. 1) . SurpnsingJy, DN thymocytes reach the DP stage in the absence of TCI< gene rearrangement (11, 18) . This finding provides evidence for a DN-to-DP differentiation event independent of rearranged TCR-I3 chain and pre-Tc~ signals. Thus, thymocytes from irradiated RAG-2 -/-mice must overcome the requirement for survival/differentiation signals normally provided by TCIL-I3 and pre--Ta chains (4-6). We hypothesized that "y radiation may be affecting genes that normally control cell death or survival events during thymocyte development. Therefore, we investigated the potential role of p53 in the generation of DP ceils in irradiated RAG-2 -~-mice. We chose p53 as a candidate gene because of its involvement in controlling ceil cycle and apoptosis after exposure to DNA-damaging agents (12) (13) (14) . Furthermore, p53 has been shown to readily undergo somatic mutation m cells after exposure to radiation (15) .
We isolated mR.NA from normal RAG-2 -/-thymocytes or from RAG-2 -/-thymocytes 2 wk after irradiation (IRtLADRAG; 8.5 Gy). After RT with random hexamer primers, PCR with gene-speclfic primers was used to amplify mRNA transcripts from the p53 gene. The RT-PCR product was generated using Pfu polymerase to avoid PCRmediated errors in the DNA sequence. The RT-PCR product was cloned, and plasmids containing p53 from several different colomes were sequenced. The p53 sequence derived from normal RAG thymocytes was identical to the previously reported sequence (12) . By contrast, several p53 gene sequences derived from irradiated RAG thymocytes revealed various nucleotide changes that would result in an altered p53 protein (Table 1) . Thus, thymocytes that developed 2 wk after radiation exposure may express mutated p53 genes. However, not all of the p53 cDNAs derived from irradiated thymocytes showed genetic alterations. This may be due to the use of total thymus rather than isolated DP thymocytes to prepare the mRNA. Nonetheless, mutated cDNAs of p53 were obtained :n 42% of the colonies we analyzed from irradiated thymuses but in none of the thymuses from nonirradiated RAG-2 -/-mice (Table 1) . These findings demonstrated that treatment with y radiation can directly mutate the p53 gene.
Our analysis of p53 protein expression revealed the presence of mutant forms of p53 in thymocytes from irradiated RAG-2 -/-but not from control RAG-2 -/-mice. Fig. 2 shows a Western blot analysis of immunoprecipitated p53 from irradiated or control RAG-2 -/-thymocyte nuclear extracts using wild-type or mutant form-specific mAbs. As a positive control for the immunoprecipitation and Western blot, we used nuclear extracts from A43l cells (Santa Cruz Biotechnology), which express a mutant form of p53 (19) (data not shown). Consistent with our D N A sequence analysis, the immunoblot shows that thymocytes from irradiated R A G -2 -/ -mice express mutant and wild-type p53.
Thus, our analysis provides direct evidence that exposure to radiation can cause the emergence o f a cell population in which the p53 gene is mutated and an altered p53 protein is expressed. Therefore, we hypothesized that mutant p53 may allow D N thymocytes from R A G -2 -/ -mice to escape apoptosis and progress to the DP stage.
To test the participation of p53 in the prevention o f DP thymocyte differentiation in R A G -2 -/ -mice, we bred
R A G -2 -/ -mice with p53-deficient mice (p53-/-). Although T cell development appears to occur normally in
p53 -/-mice (20), thymocytes from these mice are resistant to certain forms of induced programmed cell death (20) .
Analysis ofthymocytes from p 5 3-/-/ R A G-2 -/-(p 5 3 /RAG)
mice demonstrated the presence o f CD4+CD8 + thymocytes (Fig. 3) , whereas thymic cellularity did not increase by >50% from that observed in R A G -2 -/ -mice (1-3 • 106 cells/thymus). Further analysis showed that the emergence of DP cells is not simply an aberrant expression o f CD4 and CD8, but rather a progression to the next differentiation stage (7). Fig. 3 shows that, in several aspects of their developmental status, the new population of DP thymocytes in p53/RAG mice displayed a phenotype normally associated with the C D 4 + C D 8 + stage of development, including loss Mutation frequency in p53 cDNAs from ~rra&ated RAG-2-/-thymocytes is 42% (5/12), and from thymocytes of control RAG-2 -/-mice is 0% (6/6).
o f l L -2 R expression, decreased M H C class I expression, and smaller cell size (Fig. 3, a-d) (11) . W e failed to detect TCR-I3 chain rearrangement or cell surface expression o f CD3 on DP thymocytes from p53/RAG mice ( (25) . Importantly, the bd-2 survival signals can be countered by the bax gene (26) (27) (28) . In this context, tt is interesting that p53 has been shown to promote apoptosis by repressing bcl-2 expression and by upregulatmg bax transcription (29, 30) . Taken together wath our findings, we suggest that the progression to the DP stage in the ab- (25) ; (e) sublethal ~/radiation treatment (11, 18); and (.D inactivation of the p53 gene (this report). In the first three settings, DP thymocyte differentiation results from Ick-mediated signals, which allow DN thymocytes to differentiate and expand (up to a 100-fold increase in thymic cellularity) into the next stage. Thus, positive signals from lck drive differentiation and proliferation. In the last three settings, DP thymocyte differentiation is observed without a dramatic increase in thymic cellularity. In these situations, where the programmed cell death pathway is inhibited, differentiation withotit proliferation into DP stage is observed. Therefore, DN-to-DP thymocyte differentiation can occur in the absence of proliferation, and these processes are molecularly distinct. Thus, TCR-I3 selection may achieve two critical functions, differentiation and thymocyte expansion, in causing the emergence ofDP thymocytes.
